Veradigm Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Veradigm Inc (MDRX) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Veradigm Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 593M vs 667,538M combined for its competitors (0.1% combined share).
- Trending: Latest-quarter revenue run-rate is holding steady (+0.3% annualized vs trailing 12 months), vs decelerating (-4.0%) for its tracked peer group.
- Growth: Veradigm Inc generated -3.7% revenue growth year over year in Q4 2024, vs 4.3% for its competitors combined.
- Profitability: Its -178.1% net margin compares with 2.6% for the peer group.
- Scale: Veradigm Inc ranks #67 of 163 companies by market capitalization in the Cloud Computing & Data Analytics industry, holding 0.1% of industry market cap.
- Peer revenue share: Veradigm Inc accounted for 0.1% of combined revenue among its tracked peer group, down from 0.1% a year earlier.
- Peer differentiation: Revenue per employee of $0.07M compares with $0.53M for the peer group (0.1x).
- Structure: Veradigm Inc operates in the following segments: Provider, Payer, Life Science.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
MDRX Sales vs. its Competitors, Q4 2024
Veradigm Inc reported revenue contraction of 3.72 % year on year in Q4 2024, below its competitors' combined revenue growth of 4.29 %.
With a net margin of -178.11 %, Veradigm Inc reported lower profitability than its competitors (2.60 %).
Veradigm Inc generated 0.09 % of the combined sales of its peer group, down from 0.10 % a year earlier.
API endpoints for this dataset
Veradigm Inc vs. its Competitors, Q4 2024
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in Veradigm Inc reports; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Veradigm Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Veradigm Inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (4) | $12,345M | +12.3% · Accelerating |
| Similar-Size Competitors (10) | $12,345M | +12.3% · Accelerating |
| Similar Growth & Profitability (3) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Veradigm Inc's competitor groups requires a Commercial License.
For context: the Cloud Computing & Data Analytics industry grew revenue 8.1% year over year, combined, vs -3.7% for Veradigm Inc. Veradigm Inc's share of combined industry revenue moved from 0.12% to 0.11%, a loss of 0.01 percentage points.
Veradigm Inc's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Veradigm Inc | No | No | No | No |
| Competitors combined (21) | ||||
| High-Confidence Competitors (7) | ||||
| Similar-Size Competitors (10) | ||||
| Similar Growth & Profitability (8) | 0.00 % (0 of 7) | 62.50 % (5 of 8) | 50.00 % (4 of 8) | 62.50 % (5 of 8) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
MDRX Stock Performance relative to its Competitors
MDRX Stock Performance relative to High-Confidence Competitors
MDRX Stock Performance relative to Similar-Size Competitors
MDRX Stock Performance relative to Similar Growth & Profitability Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Onemednet Corporation | 282.9% | Outperformed |
| 2 | Premier Inc | 282.9% | Outperformed |
| 3 | Nrc Health | 282.9% | Outperformed |
| 4 | Aspen Technology inc | 282.9% | Outperformed |
| 5 | Teradata Corporation | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Veradigm Inc's best-performing competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Veradigm Inc's Comment on Competition and Industry Peers
Additionally, many of our prospective clients have invested substantial personnel and financial resources to implement and integrate competing solutions to ours. As a consequence, they may be reluctant or unwilling to migrate to our solutions. Third-party developers may be reluctant to build application services on our platform since they have invested in other competing technology platforms.
We compete primarily with numerous types of organizations, including developers of revenue cycle and practice management software and services, large system integrators, IT service providers, ambulatory and acute care EHR solutions, population health management and value-based care technologies, analytics systems, care management solutions and post-acute solutions. We generally compete on the basis of several factors, including breadth and depth of services (including our open architecture and the level of solution integration across care settings), integrated platform, regulatory compliance, reputation, reliability, accuracy, security, client service, total cost of ownership, innovation and industry acceptance, expertise and experience.
Moreover, we expect that competition will continue to increase as a result of consolidation in both the IT and healthcare industries. If one or more of our competitors or potential competitors were to merge or partner with another of our competitors, the change in the competitive landscape could adversely affect our ability to compete effectively.
Our principal existing competitors in these markets include, but are not limited to (in alphabetical order) AdvancedMD, athenahealth Inc., Cerner Corporation, Change Healthcare, CPSI (Computer Programs and Systems Inc.), CureMD Healthcare, eClinicalWorks, Enli Health Intelligence, Epic Systems Corporation, Evolent Health, GE Healthcare, Greenway Medical Technologies, Harris Healthcare, Healthagen, Health Catalyst, Homecare Homebase (part of Hearst Health network), IBM Watson Health, IQVIA, Kareo, MEDHOST, Inc., Meditech (Medical Information Technology, Inc.), Navicure/Zirmed, NaviHealth (a Cardinal Health company), nThrive, Optum, Philips Wellcentive, Premier Inc., Quadramed, Quality Systems, Inc., Roper Industries, T-System, The TriZetto Group, Inc. (a division of Cognizant Technology Solutions, Inc.) and Wellsoft Corporation.
Publicly Traded Peers of Veradigm Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
 Veradigm Inc |
513.83 | 593.11 |
 International Business Machines Corporation |
235,510.77 | 69,868.00 |
 Cvs Health Corporation |
108,598.92 | 420,614.00 |
 Infosys Limited |
51,542.55 | 20,158.00 |
 Aspen Technology inc |
16,821.43 | 1,140.15 |
 Bentley Systems Incorporated |
14,335.83 | 1,648.32 |
| SUBTOTAL | 452,594.35 | 712,192.09 |
Sign in to see all competitors of Veradigm Inc .
Sources: see Methodology: Peer & Competitor Identification, Sourcing.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Veradigm Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Veradigm Inc's Competitors Named by the Company
Competitive relationships identified from Veradigm Inc reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Healthlynked Corp | Company report | 85% |
| Cerner Corporation | Company report | 85% |
| American Well Corporation | Company report | 85% |
| Epic Systems Corporation | Company report | 85% |
| The TriZetto Group | Company report | 85% |
| Quality Systems | Company report | 85% |
| Greenway Medical Technologies | Company report | 85% |
| Medical Information Technology | Company report | 85% |
| Cognizant Technology Solutions | Company report | 85% |
| Roper Industries | Company report | 85% |
| Premier Inc | Company report | 85% |
| Wellsoft Corporation | Company report | 85% |
| Phreesia Inc | Company report | 85% |
| Safespace Global Corporation | Company report | 85% |
| Onemednet Corporation | Company report | 85% |
| Sharecare Inc | Company report | 85% |
| Cvs Health Corporation | Company report | 85% |
| Medavail Holdings Inc | Company report | 85% |
| Carecloud Inc | Company report | 85% |
| Nrc Health | Company report | 85% |
| International Business Machines Corporation | Company report | 85% |
Company report basis, confidence, active dates and source counts for Veradigm Inc's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.
Veradigm Inc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Veradigm Inc | Provider 79.61 % |
| International Business Machines Corporation | Software 45.63 % |
| Cvs Health Corporation | Health Services 48.03 % |
| Walgreens Boots Alliance Inc | United States Retail Pharmacy 78.78 % |
| Premier Inc | Supply Chain Services 63.48 % |
| Kyndryl Holdings Inc | Principal Markets Segment 32.24 % |
Source: operating segment revenue as reported in each company's reports (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Veradigm Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Veradigm Inc | 514 | 66,642 | -49,764 |
| International Business Machines Corporation | 235,511 | 228,850 | 36,590 |
| Cvs Health Corporation | 108,599 | 1,402,047 | 36,823 |
| Infosys Limited | 51,543 | 77,645 | 12,773 |
| Aspen Technology inc | 16,821 | 1,301,540 | 6,999 |
| Bentley Systems Incorporated | 14,336 | 284,194 | 55,597 |
| PEERS TOTAL | 452,081 | 532,230 | 12,520 |
Veradigm Inc's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent report. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Veradigm Inc | US 99.91 % |
| International Business Machines Corporation | Americas 50.14 % |
| Aspen Technology inc | Americas 55.75 % |
| Bentley Systems Incorporated | United States, Canada, and Latin America 53.29 % |
| Kyndryl Holdings Inc | Countries Excluding United States and Japan 59.79 % |
| Teradata Corporation | Non-US 44.42 % |
Source: revenue geography as reported in each company's reports (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Veradigm Inc's Position in Industry Market Structure
Market-capitalization share and concentration across all 144 companies in Veradigm Inc's industry classification, broader than the peer set above. Market cap in millions of $.Veradigm Inc ranks #67 of 144 companies by market capitalization in its industry, holding 0.08 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 581, indicating a unconcentrated market structure (see Methodology: Market Structure & Concentration).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Automatic Data Processing Inc | 121,456 | 17.82 % |
| 2 | Infosys Limited | 51,543 | 7.56 % |
| 3 | Workday Inc | 47,793 | 7.01 % |
| 4 | Zscaler Inc | 31,717 | 4.65 % |
| 5 | Cognizant Technology Solutions Corporation | 1,234 | 5.2% |
| 6 | Verisign Inc | 1,234 | 5.2% |
| 7 | Verisk Analytics Inc | 1,234 | 5.2% |
| 8 | Samsara Inc | 1,234 | 5.2% |
| 9 | Wipro Limited | 1,234 | 5.2% |
| 10 | Toast Inc | 1,234 | 5.2% |
| 67 | Veradigm Inc | 519 | 0.08 % |
Market cap and industry share for the rest of Veradigm Inc's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-11-06.
Veradigm Inc's Same-Size Peers & Stock Performance
Peers chosen by closeness in market-cap rank within the same industry classification (not the named-competitor list above). Trailing 12-month total return, 3-month price momentum, beta and Sharpe ratio vs the broad U.S. market.| Rank | Company | Market Cap | TTM Return |
|---|---|---|---|
| 62 | Yext Inc | 788 | -9.91 % |
| 63 | Cars com Inc | 752 | 19.75 % |
| 64 | Ibex Limited | 725 | 32.77 % |
| 65 | Ooma Inc | 529 | 54.86 % |
| 66 | Nerdwallet Inc | 1,234 | 12.3% |
| 67 | Veradigm Inc | 519 | - |
| 68 | Sophia Genetics Sa | 1,234 | 12.3% |
| 69 | Perion Network Ltd | 1,234 | 12.3% |
| 70 | Gravity co ltd | 1,234 | 12.3% |
| 71 | Telos Corporation | 1,234 | 12.3% |
| 72 | Ci and t Inc | 1,234 | 12.3% |
Market cap, return, momentum, beta and Sharpe ratio for the rest of Veradigm Inc's same-size peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation); returns and risk metrics as of 2026-11-09. Beta and Sharpe ratio are versus the broad U.S. equity market, not this industry.
Veradigm Inc's Profitability & Cost Structure
Trailing 12-month margins from SEC-filed financials. Operating margin is compared to the Cloud Computing & Data Analytics industry median; gross margin, EBITDA margin and capital intensity are compared to the live industry average (257 companies). See the full Cloud Computing & Data Analytics industry profitability benchmarks.| Metric | Company | Industry | Difference |
|---|---|---|---|
| Gross Margin | 50.96 % | 39.54 % (avg) | +11.4 pp |
| Operating Margin | -68.14 % | industry median | -68.3 pp |
| EBITDA Margin | 7.58 % | 2.13 % (avg) | +5.5 pp |
| Capital Intensity (Capex / Revenue) | 5.09 % | 5.89 % (avg) | -0.8 pp |
Source: CSIMarket API, trailing 12 months. SG&A and R&D as a share of revenue have limited coverage as this data is backfilled and appear only where reported. Higher capital intensity is not inherently negative; it reflects the industry's asset requirements.
Veradigm Inc's Valuation vs Competitive Position
Valuation multiples vs the Cloud Computing & Data Analytics industry average (257 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns. See the full Cloud Computing & Data Analytics industry valuation benchmarks.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | - | 27.4x | - |
| EV / EBITDA | 21.6x | 14.0x | +7.6x |
| P/B | 1.2x | 3.9x | -2.7x |
| Return on Equity | -49.29 % | industry aggregate | -56.92 % |
| Return on Invested Capital | -21.56 % | -0.39 % (avg) | -21.17 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Veradigm Inc's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in company reports.| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue Growth | 16.55 % | -3.12 % | 1.24 % | -15.18 % | 0.02 % | -60.92 % | 6.56 % | -5.25 % |
| Operating Margin | 2.32 % | -5.32 % | -1.38 % | -8.71 % | 5.14 % | -4.61 % | 5.54 % | -68.14 % |
| Return on Invested Capital | 0.98 % | -2.11 % | -0.84 % | -3.68 % | 2.45 % | -1.01 % | 1.63 % | -21.56 % |
| P/E | - | 4.9x | - | - | 35.5x | - | 29.2x | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Veradigm Inc's Strategic Group Map
Veradigm Inc is shown in red; its closest peers by combined growth, margin and ROIC are labeled. See Methodology: Strategic Group Map for how this chart is built.
Veradigm Inc's trailing-12-month revenue growth of -5.3% and operating margin of -68.1% compares with an average of 5.7% growth and -50.7% margin across its 8 closest peers by combined growth, margin and ROIC -- Veradigm Inc sits below that peer average on growth and below it on margin.
Source: CSIMarket API, trailing 12 months. Extreme outlier values (from near-zero-revenue companies) are excluded from the plotted cloud but never from the highlighted company or its labeled peers.
Veradigm Inc's BCG Growth-Share Matrix
See Methodology: BCG Growth-Share Matrix for how relative share and growth are calculated and thresholded.
Veradigm Inc falls in the Dog quadrant: relative market share of 0.00x vs its largest competitor, in an industry growing revenue 4.1% (median, trailing 12 months).
Source: CSIMarket API (market-cap share and industry revenue growth). The 10% growth and 1.0x share lines are standard textbook thresholds, not derived from this industry's own distribution.
Veradigm Inc's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | High | Industry HHI of 581 (see Industry Market Structure & Concentration above) |
| Barriers to Entry | Moderate, in line with the industry | Capital intensity (capex / revenue) of 5.09 % vs industry average 5.89 % (see Profitability & Cost Structure above) |
Note: see Methodology: Porter's Five Forces. Supplier power and buyer power are covered on Veradigm Inc's dedicated Suppliers and Customers pages, not here.
Veradigm Inc's Industry Attractiveness & Competitive Strength
See Methodology: GE/McKinsey Matrix for how the two axes are built.
Veradigm Inc falls in the Low attractiveness / Medium strength cell: Harvest.
Source: CSIMarket API, trailing 12 months. Each axis score is a simple 1(low)/2(medium)/3(high) average across its three inputs -- a transparent, disclosed simplification, not a validated academic scoring model.
Veradigm Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
No rule matched.
Weaknesses
- Operating margin 68.3 points below the industry median.
- Return on equity 56.9 points below the industry aggregate.
- Low relative market share vs the industry leader (0.00x).
Opportunities
No rule matched.
Threats
- Tracked peer group's revenue run-rate is broadly decelerating (-4.0% annualized).
Methodology: see Methodology: SWOT Analysis.
Veradigm Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Veradigm Inc | 0.72 | 1.30 | 0.25 |
| International Business Machines Corporation | 0.27 | 0.85 | 3.27 |
| Cvs Health Corporation | 0.12 | 0.86 | 0.80 |
| Infosys Limited | 0.42 | 1.98 | 0.03 |
| Aspen Technology inc | 0.67 | 2.79 | - |
| Bentley Systems Incorporated | 0.13 | 0.58 | 0.97 |
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Veradigm Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Veradigm Inc | Q4 2024 | -3.7 % | - |
| International Business Machines Corporation | Q3 2026 | +4.7 % | +25.6 % |
| Cvs Health Corporation | Q3 2026 | +5.4 % | - |
| Infosys Limited | Q1 2026 | +4.6 % | +4.9 % |
| Aspen Technology inc | Q4 2024 | +18.4 % | - |
| Bentley Systems Incorporated | Q3 2026 | +12.3 % | +57.0 % |
| PEERS TOTAL | +5.2 % | +550.5 % |
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Veradigm Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Veradigm Inc | Q4 2024 | -8.7 % | -1.9 % |
| International Business Machines Corporation | Q3 2026 | +6.0 % | +30.2 % |
| Cvs Health Corporation | Q3 2026 | +7.3 % | +17.0 % |
| Infosys Limited | Q1 2026 | +4.4 % | - |
| Aspen Technology inc | Q4 2024 | +0.0 % | +122.2 % |
| Bentley Systems Incorporated | Q3 2026 | -0.1 % | +40.2 % |
Veradigm Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Veradigm Inc | - | - | - |
| International Business Machines Corporation | 7.26% | 7.21% | 32.73% |
| Cvs Health Corporation | 4.34% | 6.34% | 14.09% |
| Infosys Limited | 20.16% | 30.31% | 33.70% |
| Aspen Technology inc | 0.04% | 0.04% | 0.05% |
| Bentley Systems Incorporated | 9.06% | 12.38% | 26.32% |
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Veradigm Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Veradigm Inc | - | 0.87 |
| International Business Machines Corporation | 21.02 | 3.37 |
| Cvs Health Corporation | 9.77 | 0.26 |
| Infosys Limited | 16.46 | 2.56 |
| Aspen Technology inc | 3,304.12 | 14.75 |
| Bentley Systems Incorporated | 44.24 | 8.70 |
| PEERS AVERAGE | 27.77 | 0.64 |
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.